Healthcare Industry MMR Vaccines Market Growth and Analysis, 2021 | Page 2

Your Catalyst To a Lucrative Business
The key target audience for global MMR vaccines market are vaccine manufacturers, vaccine research
institutes, clinical laboratories, vaccine associations, research and consulting firms, vaccine product
distributors, group purchasing organizations, vaccine raw material suppliers, immunization centers, vaccine
development institutes and organizations, hospitals and laboratories, biotechnology and biopharmaceutical
companies.
The global MMR vaccines market is segmented on the basis of product, application and geography. On the
basis of product, the global MMR vaccines market is segmented into monovalent vaccines and multivalent
vaccines. The segment “monovalent vaccines” is expected to account for the largest share of this market.
The large share of the market is attributed to rising prevalence of diseases and increasing government and
non-government initiatives for vaccine R&D activities. On the basis of application, the global MMR vaccines
market is segmented into pediatrics, adolescents, adults, elderly and so on. On the basis of geography, the
global MMR vaccines market is segmented into North America, Asia Pacific, Europe, Latin America and Middle
East & Africa.
Growth in the North America region is primarily driven by government initiatives for immunization against
diseases such as influenza and HPV in the North America countries. The key players of global MMR vaccines
market are Astellas Pharma Inc., CSL Limited, Emergent BioSolutions Inc., GlaxoSmithKline, Medlmmune LLC,
Johnson & Johnson, Merck & CO, Pfizer, Sanofi Pasteur, Serum Institute and India Pvt. Ltd.
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-
category/pharmaceuticals-industry
Follow Us: